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A B S T R A C T To evaluate whether exposure of Tn determinants at the surface of human erythrocytes, platelets, and granulocytes could arise from a somatic mutation in a hemopoietic stem cell, burst-forming unit erythroid (BFU-E) colonies, colony-forming unit granulocyte-macrophage (CFU-GM), and colonyforming unit-eosinophil (CFU-Eo) were grown from a blood group 0 patient with a typical Tn syndrome displaying two distinct populations (Tn+ and Tn-) of platelets, granulocytes, and erythrocytes. A large number of colonies was observed. Individual colonies were studied with a fluorescent conjugate of Helix pomatia agglutinin (HPA). A sizeable fraction of each of the erythroid and granulocytic colonies appeared to consist exclusively of either HPA-positive or HPA-negative cells, thereby demonstrating the clonal origin of those exhibiting the Tn marker. Similar results were obtained from a second patient. These findings establish that the HPA labeling of Tn cells is an accurate marker permitting assessment of the clonality of the human megakaryocyte (MK) colony assay. For the study of MK cultures a double-staining procedure using the HPA lectin and a monoclonal antiplatelet antibody (J-15) was applied in situ to identify all MK constituting a colony. Our results, obtained in studies of 133 MK colonies, provide definitive evidence that the human MK colony assay is clonal because all MK colonies were exclusively composed of Tn+ and Tn-INTRODUCTION Tn polyagglutinability is an acquired disorder characterized by exposure at the erythrocyte surface of receptors that are normally hidden and become available to natural antibodies occurring in most human adult sera (1) . Increasing interest in such markers is due to their frequent association with a mild hemolytic anemia or leucopenia and thrombopenia, as defined under the Tn syndrome (2) . However, the Tn receptors may also be found in apparently healthy individuals.
More recently, a Tn activation was described as preceding acute leukemia or myeloproliferative disorders, suggesting its possible role in the development of the neoplastic process (3) (4) (5) . Serological and biochemical evidence shows that N-acetyl-D-galactosamine, when covalently bound to erythrocyte glycoproteins by an alkali-labile 0 glycosidic linkage, is the chief structural determinant of Tn specificity (6, 7) . These "A-like" determinants exposed at the surface of Tn erythrocytes are recognized by several lectins such as Salvia sclarea, Dolichos biflorus, or Helix pomatia, but not by purified human anti-A antibodies (8) . Investigations carried out to further characterize Tn determinants at the molecular level have shown that the erythrocytes, platelets, and granulocytes of these patients have abnormal surface glycoproteins with a low content of sialic acid and galactose (9) (10) (11) (12) . These modifications are associated with the defect of a single galactosyltransferase involved in the biosynthesis of sugar chains O glycosidically linked to cell membrane glycoproteins (10) (11) (12) (13) (14) . On the basis of these data, it was suggested that Tn activation may originate in a mutation of a pluripotent stem cell of the bone marrow (11, 15) . This hypothesis is further supported by the finding that only a sizeable fraction of erythrocytes or platelets exhibit the Tn determinants because Tn+ and Tn-subpopulations are identifiable in the blood of the same individual (10, 11) .
In an attempt to establish the hematopoietic origin of the Tn activation, we have investigated the expression of the Tn antigen in single colonies derived respectively from burst-forming unit-erythroid colonies (BFU-E)l, colony-forming unit-granulocyte-macrophages (CFU-GM), and colony-forming unit-megakaryocytes (CFU-MK). For this purpose we have used a fluorescent derivative of the Helix pomatia (HPA) lectin, which is N-acetylgalactosamine specific and capable of recognizing Tn determinants. We were aware that only the Salvia sclarea lectin is Tn specific (16) (18) , was used. The source of granulocyte macrophage-eosinophil-colony-stimulating factor (GM-CSF) was 10% Mo-conditioned medium (19) . 2 U/ml of human urinary erythropoietin (Epo, 100 U/mg protein), obtained after DEAE-cellulose chromatography (20) , was used to grow BFU-E colonies. The activity of this Epo was determined both by the mouse polycythemic assay and BFU-E cultures, using as reference the Connaught step III sheep erythropoietin (batch 3034.1). 2 U Epo/ml were chosen because it gives an optimal number of erythroid colonies and satisfactory erythroid maturation. 4.2 X 105 blood light density cells per milliliter were plated under these conditions. At least six cultures of each were run and incubated for [12] [13] [14] [15] [16] [17] [18] (21) was used with slight modification (22) . The stimulating factor was a conditioned medium from leukocytes stimulated by phytohemagglutinin (PHA-LCM) (22, 23 were respectively plated, after adherence, in plasma clot. The cultures were studied at day 12, a time at which MK cultures reach their optimum. They were screened by immunofluorescence (24, 25) . In addition to MK colonies this method also permits the growth of a high number of granulocyte colonies. The granulocyte colonies from bone marrow cultures were only investigated by this technique.
In contrast to the methylcellulose procedure, the plasma clot technique permits the in situ study of colonies. In addition, bone marrow BFU-E were grown in plasma clot using Epo as stimulating factor and were studied by immunofluorescence.
Immunofluorescent studies. Peripheral blood erythrocytes and granulocytes were isolated after sedimentation of the blood at 1 g for 3 h. Erythrocytes were obtained at the bottom of this tube and granulocytes in the buffy coat. Blood granulocytes were purified by Ficoll-metrizoate density centrifugation. The cells were extensively washed and cytospanned for staining studies. BFU-E and CFU-GM colonies were individually picked off under an inverted microscope, washed, and studied. CFU-GM colonies were studied at day 12 or 14, whereas BFU-E were investigated at days 9, 14, and 18 .
For methylcellulose cultures, 46 and 45 of BFU-E and CFU-GM colonies were respectively studied. These colonies were selected on the basis that they were distinctly separated from neighboring colonies. Indeed, at the colony density at which CFU-GM were grown (70 colonies per dish), 35% do not arise from a single cell origin (26) . This difficulty could be overcome by selecting well separated colonies. In addition, BFU-E colonies were recognized under an inverted microscope by their red or pink color (hemoglobinized cells). Immunofluorescent studies were performed after fixation of the cells for 10 min in pure methanol. The smears were extensively washed in cold PBS and 100 ul of 10-2 diluted Helix pomatia FITC conjugate (Industrie Biologique Franqaise, France 1 mg/ml) was added. The incubation was continued for 30 min at 4°C, and the smears were extensively washed in cold phosphate-buffered saline (PBS). Before examination under the microscope the slides were mounted with a coverslip in glycerin-buffered PBS. Similar conditions of assay were used for immunofluorescent studies of platelets and MK colonies. Therefore, platelets were first isolated from peripheral blood, washed, and resuspended in the culture medium. Aliquots of 5_106 platelets were distributed in 35-mm petri dishes, and the medium was allowed to clot. From this step, a similar procedure was used for staining platelets or MK colonies. A double immunofluorescence staining was performed using an HPA-tetramethylrhodamin isothiocyanate (TRITC) conjugate to visualize the Tn antigen and a monoclonal antiplatelet antibody-fluorescein isothiocyanate (FITC) conjugate (J-15) to identify the MK. The monoclonal antibody (J-15) binds to normal human platelets but not to Glanzman's thrombasthenic platelets,2 suggesting that the antigenic structure recognized is tightly linked to the glycoprotein lIb-IIIa complex. As shown (25) , the monoclonal antibody, J-15, recognizes all the mature and immature MK without staining other cell types. Thus, by combination of the fluorescein-and rhodamin-labeled reagents, it is possible to specifically identify in situ all the MK colonies and to check them for the presence or the absence of the Tn antigen.
For this purpose, the clots were dehydrated in the petri dish with filter papers and then fixed for 5 (Table I) . In each colony, erythroblasts were either positive or negative with no intermediate cells (Fig. 1B) . However, in three colonies of 46, a minority of cells (<5%) of one type (Tn+ or Tn-) were mixed with those of other types.
In methylcellulose, the cells can move more easily than in plasma clot, and may thus migrate from one colony to another during the pipetting procedure. This prompted us to perform the same investigation in plasma clot, in which case the colonies can be studied in situ. In this case, no mixture of Tn+ and Tn-cells could be demonstrated. The same proportion of Tn+ and Tn-colonies was found in cultures of peripheral and bone marrow precursors. In addition, BFU-E colonies were screened at different periods of culture (days 9, 14, and 18), but a mixture of Tn+ and Tncells was never detected. In patient B.A., 95% of the erythrocytes were labeled by HPA-FITC. Eight BFU-E colonies were studied, seven of them exhibiting the Tn marker, while the eighth was negative.
As an additional control, we studied erythroblasts from two blood group 0 adults and two blood group O newborns in culture but no HPA staining was detected in any cells of the colonies.
Granulocytic lineage. Granulocytes were isolated from the buffy coat and labeled by the HPA immunofluorescence procedure (Fig. 2a) . As seen with erythrocytes, the granulocytes were either heavily labeled or negative. Granulocytes (517) were scored, of which only 29% were labeled by HPA.
CFU-GM and CFU-eosinophil (Eo) colonies were grown from peripheral blood and from bone marrow.
A
The number of colonies was markedly above the normal range because we found 192/106 cells in peripheral blood and 1,900/106 cells in bone marrow cultures (normal range: 50 to 100/106 cells for peripheral blood, maximum value 103/106 cells for bone marrow). As mentioned above, the Tn antigen was investigated either in methylcellulose or in plasma clot. Some 183 colonies were studied and 58% were positive (Table  I) . Once again each colony was composed either of positive or of negative cells (Fig. 2B) . Morphological investigations carried out after immunofluorescence labeling showed that most of the Tn blood colonies grown in the presence of Mo medium were composed of eosinophils, whereas the majority of bone marrow colonies grown in the presence of PHA-LCM were comprised of neutrophils and monocytes. A slight difference was observed in the distribution of Tn marker B FIGURE 1 Immunofluorescent detection of Tn antigen on erythrocytes (1A) and BFU-E colonies (1B) using a FITC of the HPA lectin. (1A) Smears of washed erythrocytes from the Tn patient (P.L.) were fixed with methanol, washed in PBS, and reacted with 100 ul of HPA-FITC (10 ug/ml in PBS) for 30 min at 4°C. After extensive washings in cold PBS, the smears were examined under a fluorescent microscope equipped with epi-illumination. 73% of the erythrocytes were labeled (Tn+ cells). Negative erythrocyte (Tn-cells) are not visible on this picture. (1B) BFU-E colonies from the peripheral blood of the patient (P.L.) were grown by the methylcellulose technique in the presence of 2 U Epo. Colonies were picked off and cytocentrifuged and the HPA-FITC was applied after fixation with methanol. The colonies were either entirely stained (73%) or were negative (27%). A typical positive burst colony is shown. The slight difference in fluorescence intensity among cells within the colony were not obvious on smears and results from the photographic procedure. Fig. 3) .
It was also possible to demonstrate by this technique that the average number of MK per colony was six and that there was no difference in the distribution of MK per colony in Tn+ and Tn-colonies (Fig. 4 
DISCUSSION
Because the presence of a dual population of cells is well established within Tn bloods (12), we have investigated the level of cell differentiation at which the Tn antigen might be expressed. The presence of Tn determinants was therefore explored by HPA labeling of BFU-E, CFU-GM, and CFU-MK colonies derived from blood and/or bone marrow progenitors from a group 0, Tn patient. Two possible results were expected. Firstly, a mixture of Tn+ and Tn-cells might coexist within each colony. Secondly, a dual population of colonies might be found, one entirely positive and the other entirely negative for the Tn marker.
The present study clearly demonstrates that the second eventuality occurred, indicating that two different populations of stem cells are present in the bone marrow of the two Tn patients investigated: one is normal (Tn-progenitors), and the other exhibits the somatic mutation (Tn+ progenitors). The expression of the Tn antigen on the cells contained in each colony was independent of their stage of maturation. In fact, in BFU-E colonies, the maturation of erythroblasts is not entirely synchronous, whereas the Tn antigen was similarly expressed on all cells of the colony. The Tn marker was found both at early periods of culture when the erythroblasts are mostly immature and at late periods, when they are fully mature. These results clearly establish that Tn cannot be considered as an antigen of maturation.
The clonal expression of Tn antigen in erythroid and granulocytic colony assays was confirmed with a blood sample from a second 0 patient (B.A.). We found that this patient had numerous Tn+ circulating cells because 95, 81, and 82% of peripheral erythrocytes, A Elilli B _ platelets, and granulocytes, respectively, were labeled by HPA-FITC. As compared with the results obtained with the first patient, P.L., (Table I) , it is obvious that the proportion of Tn+ cells in peripheral blood varies over a rather wide range from one individual to another. The nature of the mechanism that controls the phenomenon is unknown.
Other blood group antigens are present in erythroid (32) . However, we have also observed that the number of human MK per colony is highly variable from one colony to another, with a semi-normal distribution ranging from 2 to 23 (Fig.  4) . In contrast with murine cultures (31) , no single isolated MK were observed. The present study has thus afforded clear evidence that the mutation responsible for Tn reactivation has occurred in a pluripotent stem cell, and also that this mutation does not bring any significant proliferative advantage during the pathway from the commited progenitors to the mature cells. However, this study does not permit direct demonstration of the occurrence of the Tn antigen on stem cells. For the erythroid and MK lineages, the same proportion of Tn+ cells was observed on the erythrocytes and BFU-E colonies on one hand, and in platelet and MK colonies on the other. As far as the granulocytic lineage is concerned, an even higher proportion of Tn+ CFU-GM or CFU-Eo colonies was observed as compared with mature granulocytes (patient P.L.). This result might be explained by a peripheral destruction of Tn granulocytes by natural antibodies.
A slight difference in the proportion of Tn+ and Tncolonies was observed between each hematopoietic lineage, which cannot be explained by this study. It could be tentatively ascribed either to differences in the commitment of hematopoietic precursors from the pluripotent stem cells or to changes in the rate of selfrenewal from one type of commited stem cell to another.
Thus, it must be assumed that the Tn mutation has occurred in a single pluripotent stem cell followed by a clonal expansion. As no proliferative advantage was observed after the commitment, this advantage should take place either in the proliferative compartment of the pluripotent stem cell or during the process of commitment. In the near future, it will be possible to investigate these phenomena with the development of long-term bone marrow culture techniques (33) and pluripotent stem cell assays in man (34) .
At the present time, we are of the opinion that Tn activation results from clonal expansion and for this reason may be considered as being equivalent to a preleukemic state. As also noticed by others (35) , the Tn transformation may be compared to paroxysmal noctural hemoglobinuria because both disorders depend on a membrane abnormality, which itself results from a mutation occurring in a pluripotent stem cell (12, 36, 37) . In both conditions, two subpopulations of myeloid cells coexist (12, 38) , and the development of acute leukemia can be occasionally observed (3-5, 39, 40) . Tn polyagglutinability is now a well characterized mutation occurring in a pluripotent stem cell, and it will be a useful model for future studies of the role of blood group antigens in the proliferation of pluripotent stem cells.
